Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Change in Cash (2020 - 2025)

Historic Change in Cash for CureVac (CVAC) over the last 6 years, with Q3 2025 value amounting to $33.0 million.

  • CureVac's Change in Cash fell 9139.04% to $33.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$138.5 million, marking a year-over-year decrease of 23489.51%. This contributed to the annual value of $83.7 million for FY2024, which is 18434.23% up from last year.
  • According to the latest figures from Q3 2025, CureVac's Change in Cash is $33.0 million, which was down 9139.04% from -$50.9 million recorded in Q2 2025.
  • In the past 5 years, CureVac's Change in Cash ranged from a high of $302.4 billion in Q4 2021 and a low of -$348.0 billion during Q3 2021
  • Moreover, its 5-year median value for Change in Cash was -$45.4 million (2025), whereas its average is -$953.6 million.
  • In the last 5 years, CureVac's Change in Cash soared by 5766714.22% in 2021 and then crashed by 8411308.11% in 2022.
  • Quarter analysis of 5 years shows CureVac's Change in Cash stood at $302.4 billion in 2021, then plummeted by 100.01% to -$37.5 million in 2022, then crashed by 70.64% to -$63.9 million in 2023, then dropped by 17.68% to -$75.2 million in 2024, then skyrocketed by 143.89% to $33.0 million in 2025.
  • Its last three reported values are $33.0 million in Q3 2025, -$50.9 million for Q2 2025, and -$45.4 million during Q1 2025.